CERVICOGENIC MYOFASCIAL PAIN: BEST PRACTICE
- Authors: Vorob'eva O.V.1
-
Affiliations:
- Sechenov First Moscow State Medical University (Sechenov University)
- Issue: Vol 21, No 9 (2019)
- Pages: 136-141
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/95356
- DOI: https://doi.org/10.26442/20751753.2019.9.190674
- ID: 95356
Cite item
Full Text
Abstract
Myofascial pain (MFP) is the most frequent cause of chronic pain of various localizations including back pain, headaches and cervical pain. Cervicogenic MFP is an important component of the office syndrome. Understanding of causes, diagnostics and treatment of MFP will help to prevent excessive negative impact of chronic pain on public health. Local use of Voltaren Emulgel may result in quick reduction of acute MFP after use in monotherapy. It also can be used as an important complementation to multimodal therapy in recurrent and chronic forms of myofascial pain syndromes.
Full Text
##article.viewOnOriginalSite##About the authors
Olga V. Vorob'eva
Sechenov First Moscow State Medical University (Sechenov University)
Email: ovvorobeva@mail.ru
д-р мед. наук, проф., ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет) Москва, Россия
References
- Harden RN, Cottrill J, Gagnon CM et al. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study. Headache 2009; 49 (5): 732-43.
- Duyur Cakit B, Genq H, Altunta? V, Erdem HR. Disability and related factors in patients with chronic cervical myofascial pain. Clin Rheumatol 2009; 28 (6): 647-54.
- Custodio L, Carlson CR, Upton B et al. The impact of cigarette smoking on sleep quality of patients with masticatory myofascial pain. J Oral Facial Pain Headache 2015; 29 (1): 15-23.
- Воробьева О.В., Лысенко А.С. Комбинированный гель, содержащий ибупрофен и левоментол, в терапии острой боли в шее и/или плечевом поясе, вызванной болезненным мышечным спазмом. Лечащий врач. 2018; 10-22: 39-43. [Vorob'eva O.V., Lysenko A.S. Kombinirovannyi gel', soderzhashchii ibuprofen i levomentol, v tera-pii ostroi boli v shee i/ili plechevom poiase, vyzvannoi boleznennym myshechnym spazmom. Lec-hashchii vrach. 2018; 10-22: 39-43 (in Russian).]
- Desai MJ, Bean MC, Heckman TW et al. Treatment of myofascial pain. Pain Manag 2013; 3 (1): 67-79.
- Jorge L. Topical analgesics. J Pain Res 2011; 4: 11-24.
- Sintov AC, Botner S. Transdermal drug delivery using microemulsion and aqueous systems: influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems. Int J Pharm 2006; 311 (1-2): 55-62.
- Riess W, Schmid K, Botta L et al. The percutaneous absorption of diclofenac. Arzneimittelforsc-hung 1986; 36 (7): 1092-6.
- Имаметдинова Г.Р., Иголкина Е.В. Топические формы диклофенака в лечении заболеваний опорно-двигательного аппарата. Мед. совет. 2018; 12: 98-104. [Imametdinova G.R., Igolkina E.V. Topicheskie formy diklofenaka v lechenii zabolevanii oporno-dvigatel'nogo apparata. Med. sovet. 2018; 12: 98-104. (in Russian).]
- Бадокин В.В. Значение локальной терапии НПВП в клинической практике. Врач. 2012; 4: 81-5. [Badokin V.V. Znachenie lokal'noi terapii NPVP v klinicheskoi praktike. Vrach. 2012; 4: 81-5 (in Russian).]
